Cleveland Jewish News: William Schiemann, associate professor of general medical sciences, led a team of researchers who found a link between a micro ribonucleic acid molecule and late-stage breast cancer. “Our micro RNA inactivates [a protein called] Bim, and we think this leads to chemo resistance to these metastatic cancers,” Schiemann said. Lower Bim levels, coupled with higher miR-181a levels, allow the spread of cancer.
Medicine’s William Schiemann and researchers target molecule’s role in late-stage breast cancer
- History’s Ted Steinberg discussed the New York City “growth imperative”
- University Circle church to celebrate new renovations with free concert Sunday
- Celebrate Halloween with Greek Life at “Greek-or-Treat”
- Dental/nursing student William Jacobson wins multiple awards
- 5 questions with…new Assistant Professor of Sociology Cassi Pittman